STATE STREET CORP - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,308,872
-60.6%
586,008
+6.2%
0.00%
Q2 2023$5,864,380
+67.0%
551,682
+30.8%
0.00%
Q1 2023$3,512,161
-54.0%
421,628
-49.0%
0.00%
Q4 2022$7,637,806
+44.5%
827,498
+101.1%
0.00%
Q3 2022$5,284,000
+4.7%
411,490
+7.7%
0.00%
Q2 2022$5,048,000
-74.9%
382,106
-59.9%
0.00%
-100.0%
Q1 2022$20,082,000
+5.1%
954,025
+19.7%
0.00%0.0%
Q4 2021$19,116,000
-17.8%
796,852
-12.9%
0.00%0.0%
Q3 2021$23,269,000
-23.6%
914,671
+1.1%
0.00%
-50.0%
Q2 2021$30,457,000
+4.9%
904,836
+21.1%
0.00%0.0%
Q1 2021$29,025,000
+8.0%
747,288
+72.1%
0.00%0.0%
Q4 2020$26,884,000
+249.9%
434,108
+89.2%
0.00%
+100.0%
Q3 2020$7,683,000
+20.7%
229,412
-14.1%
0.00%
Q2 2020$6,366,000
-5.5%
267,139
-9.2%
0.00%
-100.0%
Q1 2020$6,739,000
+40.2%
294,281
+73.4%
0.00%
Q4 2019$4,807,000
+60.9%
169,744
+22.1%
0.00%
Q3 2019$2,987,000138,9790.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$7,551,0001.86%
RTW INVESTMENTS, LP 3,644,248$92,710,0001.40%
Cormorant Asset Management, LP 1,278,276$32,519,0001.32%
Redmile Group, LLC 2,381,958$60,597,0001.06%
HighVista Strategies LLC 47,594$1,211,0000.80%
Birchview Capital, LP 15,000$382,0000.26%
GILDER GAGNON HOWE & CO LLC 1,123,355$28,578,0000.15%
Artal Group S.A. 250,000$6,360,0000.14%
Tekla Capital Management LLC 99,263$2,525,0000.08%
Casdin Capital, LLC 120,000$3,053,0000.08%
View complete list of STOKE THERAPEUTICS INC shareholders